Zacks.com on MSN1d
Jabil (JBL) Surpasses Market Returns: Some Facts Worth Knowing
Jabil (JBL) reachead $163.62 at the closing of the latest trading day, reflecting a +1.11% change compared to its last close.
SG Americas Securities LLC Sells 4,476 Shares of Jabil Inc. (NYSE:JBL)
SG Americas Securities LLC reduced its holdings in Jabil Inc. (NYSE:JBL – Free Report) by 70.7% during the fourth quarter, ...
Jabil acquires Pharmaceutics International, terms undisclosed
Jabil (JBL) announced the acquisition of Pharmaceutics International, completed February 3. “Jabil is very pleased to ...
Chicago Partners Investment Group LLC Purchases Shares of 1,971 Jabil Inc. (NYSE:JBL)
Chicago Partners Investment Group LLC purchased a new stake in Jabil Inc. (NYSE:JBL – Free Report) during the 4th quarter, ...
Zacks.com on MSN1d
JBL Boosts Healthcare Portfolio With Strategic Buyout: Stock to Gain?
Jabil acquires Pharmaceutics International to enhance commercial prospects in the emerging market of CDMO services.
Fortune 500 firm acquires Hunt Valley drug manufacturer
A Hunt Valley drug manufacturing company with more than 300 employees has been acquired by a Fortune 500 firm.
Jabil director Holland sells 3,400 common shares
In a regulatory filing, Jabil (JBL) director Christopher Holland disclosed the sale of 3,400 common shares of the company on January 31 at a ...
Hosted on MSN6d
Jabil (JBL) Beats Stock Market Upswing: What Investors Need to Know
The latest trading session saw Jabil (JBL) ending at $162.64, denoting a +1.03% adjustment from its last day's close. The stock outperformed the S&P 500, which registered a daily gain of 0.53%.
Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc. Announce Exit from Pharmaceutics International, Inc.
A consortium of investors led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience ...